Net Cash Provided by (Used in) Financing Activities in USD of Cellectar Biosciences, Inc. from 2010 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Cellectar Biosciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2024.
  • Cellectar Biosciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $43.8M.
  • Cellectar Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $61.4M, a 168% increase from 2023.
  • Cellectar Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $22.9M, a 139% increase from 2022.
  • Cellectar Biosciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $9.61M, a 670% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

Cellectar Biosciences, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $43.8M +$43.8M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q1 2023 $3.00* Jan 1, 2023 Mar 31, 2023 10-Q/A 2024-10-29
Q1 2021 $1.21M +$1.21M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q1 2020 $0 +$811 Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-07
Q1 2019 -$811* -$83 Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 -$728* -$2.85M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-06
Q1 2017 $2.85M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q1 2013 $5.05M +$5.05M Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
Q1 2012 -$544* +$50K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q1 2011 -$50.5K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04

Cellectar Biosciences, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $61.4M +$38.5M +168% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 $22.9M +$13.3M +139% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2022 $9.61M +$8.36M +670% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-10-29
2021 $1.25M -$59.3M -97.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $60.5M +$51.5M +571% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 $9.02M -$6M -39.9% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 $15M +$5.09M +51.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-09
2017 $9.93M -$6.01M -37.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-26
2016 $15.9M Jan 1, 2016 Dec 31, 2016 10-K 2018-03-21
2012 $7.85M -$1.66M -17.5% Jan 1, 2012 Dec 31, 2012 10-K 2013-03-28
2011 $9.52M +$6.44M +209% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-28
2010 $3.08M Jan 1, 2010 Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.